Dr. Plant is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
225 E Chicago Ave
Chicago, IL 60611Phone+1 800-543-7362Fax+1 971-350-1559
Summary
- I am a pediatric neuro-oncologist with a focus on early phase clinical trials for pediatric brain tumors and immunotherapy.
Education & Training
- Brigham and Women's Hospital/Dana-Farber Cancer Institute/Harvard Medical SchoolFellowship, Pediatric Neuro-Oncology, 2015 - 2016
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2013 - 2016
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 2010 - 2013
- Stanford University School of MedicineClass of 2010, MD
- Whittier CollegeBA, Biochemistry, minor in History , Summa cum laude, 2002 - 2006
Certifications & Licensure
- IL State Medical License 2020 - 2026
- CA State Medical License 2011 - 2021
- MA State Medical License 2013 - 2017
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- AM Khokhar Research Scholar Vivienne Khokhar, 2020-2021
- Will Irwin Memorial Fund Researcher Pediatric Cancer Research Foundation, 2020-2021
- Young Investigator Award Adpative Technologies, Inc, 2016
- Join now to see all
Clinical Trials
- rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG Start of enrollment: 2022 Jan 10
Publications & Presentations
PubMed
- Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastoma.Zahra Motahari, Javier J Lepe, Malia R Bautista, Clay Hoerig, Ashley S Plant-Fox
Biorxiv. 2024-03-03 - 4 citationsCurrent advances in immunotherapy for atypical teratoid rhabdoid tumor (ATRT).Son Tran, Ashley S Plant-Fox, Susan N Chi, Aru Narendran
Neuro-Oncology Practice. 2023-08-01 - 1 citationsRecurrent pediatric infratentorial ependymomas: a systematic review and meta-analysis on outcomes and molecular classification.Eric Y Montgomery, Vineeth Thirunavu, Manasa Pagadala, Nathan A Shlobin, Ashley S Plant-Fox
Journal of Neurosurgery. Pediatrics. 2023-02-01
Journal Articles
- Immunophenotyping of pediatric brain tumors: Correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response.Plant AS, Koyama S, Sinai C, Solomon IH, Griffin GK, Ligon KL, Bandopadhayay P, Betensky R, Emerson R, Dranoff G, Kieran MW, Ritz J., Journal of Neuro-Oncology, 1/10/2018
- Single-Cell Transcriptomes Reveal the Mechanism for a Breast Cancer Prognostic Gene PanelChaitali S Nangia, Lilibeth Torno, William G Loudon, Mustafa H Kabeer, Ashley S Plant, Shengwen Calvin Li, Oncotarget
- Immunophenotyping of Pediatric Brain Tumors: Correlating Immune Infiltrate with Histology, Mutational Load, and Survival and Assessing Clonal T Cell ResponseIsaac H Solomon, Mark W Kieran, Gabriel K Griffin, Pratiti Bandopadhayay, Jerome Ritz, Ashley S Plant, Keith L Ligon, Glenn Dranoff, Journal of Neuro-Oncology
Abstracts/Posters
- Updated findings from a phase 1b study of unesbulin (PTC596) in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG) and high grade glioma (HGG): a re...Lazow MA, Baxter P, Stanek J, Lane A, Rodriguez DP, Kumar SS, Leach JL, Mikael L, Fuller C, Boue DR, Pierson CR, Thomas D, Breneman J, Palmer J, Li XN, Salloum R, Ashl..., 2023 Society of Neuro-Oncology Pediatric Neuro-Oncology Research Conference, Washington, DC, 6/22/2023
- ROVER: A phase I/2 study of avapritinib in pediatric patients with solid tumors dependent on KIT or PDGFRA signalingKoschmann C, Hoffman L, Kramm K, Plant-Fox A, Abdelbaki M, Bui A, Casanova M, Morgenstern D, Swamy P, Shi H, Hong J, Rinne M, Chi SN, 2023 Society of Neuro-Oncology Pediatric Neuro-Oncology Research Conference, Washington, DC, 6/22/2023
- A two-part, phase 1 study of Rhenium-186 NanoLiposome (186RNL) delivered via convection enhanced delivery (CED) for recurrent or progressive childhood ependymoma and h...Plant-Fox A, DeCuypere M, Lam SK, Quijano C, Sereno L, Bao A, LaFrance N, Hedrick M, Brenner A, Society of Neuro-Oncology 2023 Annual Meeting, Tampa, Florida, 11/17/2022
- Join now to see all
Lectures
- Development of a neo-antigen heat shock protein vaccine plus checkpoint blockade for the treatment of diffuse intrinsic pontine gliomaSan Francisco, CA - 7/1/2019
- Immunophenotyping of pediatric brain tumors: Correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response.Pediatric Neuro-Oncology Basic and Translational Research Conference, New York, NY - 6/16/2017
Authored Content
- Precision Medicine in Pediatric Neurooncology: A ReviewDecember 2017
Press Mentions
- Will Irwin Memorial Fund RecipientJanuary 1st, 2023
- New clinical trial uses immunotherapy to treat Diffuse Intrinsic Pontine Glioma (DIPG)October 19th, 2022
- New Clinical Trial Launches at Lurie Children'sMay 10th, 2022
Grant Support
- K12 Paul Calabresi Clinical Oncology Award: Training in Nervous System TumorsNIH2014–2016
- Team Jack Foundation GrantTeam Jack FoundationPresent
- AM Khokhar Research ScholarVivienne KhokharPresent
Professional Memberships
- ISPNOMember
- Society for Neuro-Oncology (SNO)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: